Table III.
Particle Size of the Formulations
| Formulations | Particle size D[4,3] μm | ||||
|---|---|---|---|---|---|
| PE | VP | PP | PC | CU | |
| Drug powder (A) | 37.52 ± 1.91 | 40.65 ± 1.00 | 47.81 ± 1.76 | 38.07 ± 1.67 | 31.39 ± 0.98 |
| Drug/ovalbumin/gelatin at 1:1:2 (B) | 25.43 ± 2.57 | 29.89 ± 0.85 | 31.31 ± 1.35 | 75.93 ± 1.14 | – |
| Drug/ovalbumin/gelatin at 2:3:5 (C) | 32.34 ± 1.07 | 35.78 ± 1.55 | 36.70 ± 0.93 | 64.75 ± 4.45 | – |
| Drug/ovalbumin/gelatin at 1:2:3 (D) | – | – | – | – | 121.36 ± 1.96 |
| Drug/ovalbumin/gelatin at 1:3:4 (E) | – | – | – | – | 184.68 ± 3.19 |
| Statistical analysis | |||||
| F | 29.048 | 63.780 | 110.013 | 142.872 | 3,565.634 |
| Significance | P < 0.01 | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 |
| Tukey’s HSD | |||||
| A and B | P < 0.01 | P < 0.001 | P < 0.001 | P < 0.001 | – |
| A and C | P < 0.05 | P < 0.01 | P < 0.001 | P < 0.001 | – |
| B and C | P < 0.05 | P < 0.01 | P < 0.01 | P < 0.01 | – |
| A and D | – | – | – | – | P < 0.001 |
| A and E | – | – | – | – | P < 0.001 |
| D and E | – | – | – | – | P < 0.001 |
Mean ± SD (N = 3)